Found: 9
Select item for more details and to access through your institution.
Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes: A post hoc analysis of pooled data from four phase 3 randomized clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2763, doi. 10.1111/dom.14534
- By:
- Publication type:
- Article
Low‐dose empagliflozin as adjunct‐to‐insulin therapy in type 1 diabetes: A valid modelling and simulation analysis to confirm efficacy.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 427, doi. 10.1111/dom.13945
- By:
- Publication type:
- Article
1198-P: The M-EASE Studies: A Modeling and Simulation Approach to Further Characterize the Efficacy of Low-Dose Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes (T1DM).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1198-P
- By:
- Publication type:
- Article
Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial.
- Published in:
- Clinical Infectious Diseases, 2006, v. 43, n. 10, p. 1347, doi. 10.1086/508352
- By:
- Publication type:
- Article
UCTM—An Ambidextrous Service Innovation Framework—A Bottom-Up Approach to Combine Human- and Technology-Centered Service Design.
- Published in:
- Systems, 2019, v. 7, n. 2, p. 23, doi. 10.3390/systems7020023
- By:
- Publication type:
- Article
Randomized, double‐blind, placebo‐controlled dose‐finding study of the dipeptidyl peptidase‐4 inhibitor linagliptin in pediatric patients with type 2 diabetes.
- Published in:
- Pediatric Diabetes, 2018, v. 19, n. 4, p. 640, doi. 10.1111/pedi.12616
- By:
- Publication type:
- Article
Linagliptin added to sulphonylurea in uncontrolled type 2 diabetes patients with moderate-to-severe renal impairment.
- Published in:
- Diabetes & Vascular Disease Research, 2014, v. 11, n. 1, p. 34, doi. 10.1177/1479164113507068
- By:
- Publication type:
- Article
Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events.
- Published in:
- Cardiovascular Diabetology, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12933-015-0215-2
- By:
- Publication type:
- Article
Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article